(Q37975092)

English

MET signaling: novel targeted inhibition and its clinical development in lung cancer

scientific article published on February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

MET signaling: novel targeted inhibition and its clinical development in lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1 reference

based on heuristic

inferred from title

author name string

Yan Feng

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Praveena S Thiagarajan

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Patrick C Ma

3

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Journal of Thoracic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

459-467

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

10.1097/JTO.0B013E3182417E44

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37975092&oldid=2158471724"